Daiichi Sankyo Company, Limited (DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions Transcript

PresentationKentaro AsakuraCorporate Officer, Head of Corporate Communications Deptt, Global Corporate Planning & Mngmt Thank you for waiting, everybody. We'll now start Daiichi Sankyo's ESMO 2025 highlights. This is Ken Asakura from Corporate Communications, and I will be the moderator today. First, about the language for this event. Presentation will be in English, and Q&A will be in both English and Japanese. Simultaneous interpretation is provided, so please click the interpretation icon at the bottom o ...